Determining the post-elimination level of vaccination needed to prevent re-establishment of dog rabies

PLoS Negl Trop Dis. 2019 Dec 2;13(12):e0007869. doi: 10.1371/journal.pntd.0007869. eCollection 2019 Dec.

Abstract

Background: Once a canine rabies-free status has been achieved, there is little guidance available on vaccination standards to maintain that status. In areas with risk of reintroduction, it may be practical to continue vaccinating portions of susceptible dogs to prevent re-establishment of canine rabies.

Methods: We used a modified version of RabiesEcon, a deterministic mathematical model, to evaluate the potential impacts and cost-effectiveness of preventing the reintroduction of canine rabies through proactive dog vaccination. We analyzed four scenarios to simulate varying risk levels involving the reintroduction of canine rabies into an area where it is no longer present. In a sensitivity analysis, we examined the influences of reintroduction frequency and intensity, the density of susceptible dog population, dog birth rate, dog life expectancy, vaccine efficacy, rate of loss of vaccine immunity, and the basic reproduction number (R0).

Results: To prevent the re-establishment of canine rabies, it is necessary to vaccinate 38% to 56% of free-roaming dogs that have no immunity to rabies. These coverage levels were most sensitive to adjustments in R0 followed by the vaccine efficacy and the rate of loss of vaccine immunity. Among the various preventive vaccination strategies, it was most cost-effective to continue dog vaccination at the minimum coverage required, with the average cost per human death averted ranging from $257 to $398 USD.

Conclusions: Without strong surveillance systems, rabies-free countries are vulnerable to becoming endemic when incursions happen. To prevent this, it may be necessary to vaccinate at least 38% to 56% of the susceptible dog population depending on the risk of reintroduction and transmission dynamics.

MeSH terms

  • Animals
  • Disease Eradication*
  • Disease Transmission, Infectious / prevention & control*
  • Dog Diseases / prevention & control*
  • Dogs
  • Drug Utilization / statistics & numerical data*
  • Models, Theoretical
  • Rabies / prevention & control
  • Rabies / veterinary*
  • Rabies Vaccines / administration & dosage*

Substances

  • Rabies Vaccines

Grants and funding

The author(s) received no specific funding for this work.